Certified by Founder Lodge
Adcendo

START UP
1 Disclosed Funding Rounds $135,000,000
0 Participating Investments
- Founded date
2017
- Operating Status
Active
- Last Funding Type
Seed
- Company Type
For Profit
- Website
- Contact
- Social Links
Adcendo seeks to develop antibody-drug conjugates to create new medicines for cancer patients with a significant unmet need.
The company was founded in 2017 in Copenhagen, as a spin-out f
Date | Round | Raised | Participating Investors |
---|---|---|---|
November, 26 ,2024 | Series B | $135,000,000 |